| Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease B Yi, JJ Sahn, PM Ardestani, AK Evans, LL Scott, JZ Chan, S Iyer, A Crisp, ... Journal of neurochemistry 140 (4), 561-575, 2017 | 119 | 2017 |
| Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system P Ramirez, G Zuniga, W Sun, A Beckmann, E Ochoa, SL DeVos, B Hyman, ... Progress in neurobiology 208, 102181, 2022 | 54 | 2022 |
| Pathogenic tau causes a toxic depletion of nuclear calcium R Mahoney, EO Thomas, P Ramirez, HE Miller, A Beckmann, G Zuniga, ... Cell reports 32 (2), 2020 | 33 | 2020 |
| Awakening the dark side: retrotransposon activation in neurodegenerative disorders EO Thomas, G Zuniga, W Sun, B Frost Current opinion in neurobiology 61, 65-72, 2020 | 25 | 2020 |
| Tau‐induced deficits in nonsense‐mediated mRNA decay contribute to neurodegeneration G Zuniga, S Levy, P Ramirez, J De Mange, E Gonzalez, M Gamez, B Frost Alzheimer's & Dementia 19 (2), 405-420, 2023 | 19 | 2023 |
| A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer’s disease (ART-AD) AC Sullivan, G Zuniga, P Ramirez, R Fernandez, CP Wang, J Li, L Davila, ... medRxiv, 2024 | 3 | 2024 |
| TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy SA Levy, G Zuniga, EM Gonzalez, D Butler, S Temple, B Frost Cell Reports Methods 2 (9), 2022 | 3 | 2022 |
| Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease G Zuniga, S Katsumura, J De Mange, P Ramirez, F Atrian, M Morita, ... Aging cell 23 (10), e14245, 2024 | 1 | 2024 |
| Selective neuronal vulnerability to deficits in RNA processing G Zuniga, B Frost Progress in Neurobiology, 102500, 2023 | 1 | 2023 |
| Deficits in Nonsense-Mediated mRNA Decay Contribute to Neurodegeneration in Tauopathy G Zuniga The University of Texas Health Science Center at San Antonio, 2022 | | 2022 |
| Advances in a C. elegans model of Alzheimer's disease for drug screening against neurodegeneration G Zuniga | | 2015 |
| A century of questions: Retrospective study of the controversy and efficacy of Alzheimer's disease models G Zuniga | | 2015 |
